Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000266020 | SCV000336549 | likely benign | not specified | 2015-10-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001579820 | SCV000513002 | likely benign | not provided | 2020-09-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551224 | SCV000627975 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777851 | SCV000913853 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000777851 | SCV002664759 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003995769 | SCV004822425 | benign | Marfan syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579820 | SCV001808618 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001579820 | SCV001952163 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535313 | SCV004729495 | benign | FBN1-related disorder | 2020-06-11 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |